Pfizer Gets Final Nod On $94M Celebrex Antitrust Settlement
A Virginia federal judge signed off Wednesday on Pfizer's $94 million settlement, including nearly $31 million in legal fees, with drug buyers who said the pharmaceutical giant extended its monopoly over...To view the full article, register now.
Already a subscriber? Click here to view full article